PETER ACCORTI: Open Payments
NPI 1801394291 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 19 payments from 10 companies in 2025. Trend: 2023 $1,405 · 2024 $1,545 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| Boston Scientific Corporation | 3 | $51 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $39 |
| Novo Nordisk Inc | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| PFIZER INC. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: VERQUVO, JARDIANCE, WATCHMAN, LifeVest, Ozempic, NEXLETOL, FUROSCIX, ELIQUIS.
Industry payments across FL — which companies pay providers there.
